DE:4YX0 Stock Latest News
Company AnnouncementsRhelion Subsidiary Ships PEX010 to King’s College London Study3d ago
Company AnnouncementsFilament Ships PEX010 to USC for Psychedelic Therapy Trial1w ago
Company AnnouncementsRhelion’s Filament Health to Supply Psilocybin Candidate PEX010 for Swedish Social Anxiety Trial2w agoCompany AnnouncementsRhelion’s Filament to Supply Psilocybin for Belgium’s First Compassionate Use Program3w ago
Company AnnouncementsRhelion Reappoints Psychedelic Research Leader as Advisor and Moves to Restructure Debt4w ago
Company AnnouncementsRhelion Subsidiary Filament to Supply Psilocybin for UCSF Trial on Meth Use Disorder in People With HIV1M ago
Company AnnouncementsRhelion Unit Ships Psilocybin Candidate for PTSD Trial in Calgary1M ago
Company AnnouncementsRhelion Subsidiary Filament Health Wins New Canadian Patent for Natural Psilocybin1M ago
Company AnnouncementsRhelion Subsidiary Supplies Psilocybin for Phase 3 Palliative Care Trial1M ago
Company AnnouncementsRhelion’s Filament Health inks psilocybin supply deal with Dutch research centre1M ago
Company AnnouncementsRhelion’s Filament Health to Supply Psilocybin Candidate PEX010 for USC Mindfulness Trial1M ago






